 |
16th Annual Award Recipient
Guillermina Lozano, Ph.D.
Professor and Chair
Department of Genetics
The University of Texas MD Anderson Cancer Center
Houston, TX
|
Dr. Lozano delivered her award lecture titled
Activities of Mutant p53 Proteins in Cancer, at the AACR Annual Meeting 2013 in Washington, D.C. The award ceremony and lecture was held on Saturday, April 6, 2013. Visit the
AACR Annual Meeting 2013 page for more information on the Annual Meeting.
The Lectureship
The AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship was established in 1998 in honor of renowned virologist and discoverer of the Friend virus, Dr. Charlotte Friend, for her pioneering research on viruses, cell differentiation and cancer. The lecture is intended to give recognition to an outstanding female or male scientist who has made meritorious contributions to the field of cancer research and who has, through leadership or by example, furthered the advancement of women in science.
Eligibility
- Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.
- The lectureship will be presented to an individual investigator.
- Institutions or organizations are not eligible for the lectureship.
Nomination Process
Nominations are closed.
Nominations may be by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves.
Selection
Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the winner will be made on the basis of the candidate's contributions to the field of cancer research and to the advancement of women in science. No regard will be given to age, race, gender, nationality, geographic location or religious or political views.
Questions?
Linda Stokes, Program Associate
linda.stokes@aacr.org
American Association for Cancer Research
17th Floor, 615 Chestnut Street
Philadelphia, PA 19106-4404
SPOTLIGHT
 |
15th Lectureship Recipient
Lisa M. Coussens, Ph. D.
Hildegard Lamfrom Chair in Basic Science
Professor and Chair, Cell & Developmental Biology
Associate Director for Basic Research, Knight Cancer Institute
Oregon Health and Science University
Portland, OR
|
Dr. Lisa M. Coussens delivered her Award lecture titled, Inflammation and Cancer: Translating Basic Research into Clinical Practice during the AACR Annual Meeting 2012. Learn more about the AACR Annual Meeting 2012.
_________________________________________________________________________________________________________________________________________________________________
Dr. Lisa M. Coussens is recognized as an accomplished basic scientist with an international reputation for her novel studies on inflammation and stromal regulation of tissue homeostasis and tumor development that now has clear translational application in the clinic. Dr. Coussens is Professor and Chair of the Department of Cell and Developmental Biology, and Associate Director for Basic Research in the Knight Cancer Institute at Oregon Health and Sciences University (OHSU) where she holds the Hildegard Lamfrom Chair in Basic Science. Dr. Coussens joined OHSU in Fall 2011 from the
University of California San Francisco (UCSF) where she was a Professor in the Department of Pathology, and Co-Leader of the Program in Cancer, Immunity and Microenvironment in the UCSF Helen Diller Family Comprehensive Cancer Center. Dr. Coussens has an international reputation for exceptional high-impact research; her pioneering studies have fueled a paradigm shift in understanding the role of the tumor microenvironment in regulating solid tumor development.
Dr. Coussens’ research focus is on the role of immune cells and their mediators as critical regulators of solid tumor development, and in understanding the molecular and cellular mechanisms that regulate leukocyte recruitment into neoplastic tissue, and the subsequent regulation those leukocytes exert on evolving cancer cells. She received her Ph.D. in Biological Chemistry from UCLA in 1993, and completed her postdoctoral fellowship in Cancer Biology at UCSF in Douglas Hanahans’ laboratory. Since establishing her own laboratory at UCSF in 1999, Dr. Coussens received the prestigious Gertrude B. Elion Award from the American Association of Cancer Research (AACR), the Mallinckrodt Award for Medical Science and a V Foundation Scholar Award for her novel discoveries regarding the role of matrix metalloproteinases and mast cells as critical regulators of epithelial cancer development.
More recently, Dr. Coussens was awarded two sequential Era of Hope Scholar Awards from the Department of Defense Breast Cancer Research Program to support her novel investigations of chronic inflammation as a regulator of breast carcinogenesis. In 2011, she and her clinical collaborators received a Susan G. Komen Promise Grant to conduct a multicenter phase Ib/II clinical trial to evaluate novel therapeutic approaches emerging from her research on the tumor microenvironment. Dr. Coussens demonstrates a deep commitment to educating and mentoring the next generation of scientists, and as such is the 2012 recipient of the AACR-Women in Cancer Research Charlotte Friend Memorial Lectureship.